A new Lancet meta-analysis of the best double-blind trial data available shows that most of the scary side effects on statin labels simply don’t hold up
(title)
More from FollowingMore posts in Following »
The Community's Independent Voice
The Community's Independent Voice
A new Lancet meta-analysis of the best double-blind trial data available shows that most of the scary side effects on statin labels simply don’t hold up
Be First to Comment